ES2080297T3 - Derivados 17-g(b)-sustituido-4-aza-5g(a)-androstan-3-ona y procedimiento de preparacion de estos. - Google Patents

Derivados 17-g(b)-sustituido-4-aza-5g(a)-androstan-3-ona y procedimiento de preparacion de estos.

Info

Publication number
ES2080297T3
ES2080297T3 ES91903236T ES91903236T ES2080297T3 ES 2080297 T3 ES2080297 T3 ES 2080297T3 ES 91903236 T ES91903236 T ES 91903236T ES 91903236 T ES91903236 T ES 91903236T ES 2080297 T3 ES2080297 T3 ES 2080297T3
Authority
ES
Spain
Prior art keywords
androstan
ona
aza
derivatives
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91903236T
Other languages
English (en)
Inventor
Achille Panzeri
Salle Enrico Di
Marcella Nesi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia SpA filed Critical Pharmacia SpA
Application granted granted Critical
Publication of ES2080297T3 publication Critical patent/ES2080297T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A INHIBIDORES DE 5ALFA-REDUCTASA ESTERODICA QUE TIENEN LA FORMULA (I) DONDE R SUB 1 ES HIDROGENO, UN GRUPO ALQUILO C SUB 1 C SUB 1 UFRE; W ES UN GRUPO (2) DONDE R SUB 2 Y R SUB 3 SE ELIGEN INDEPENDIENTEMENTE ENTRE EL GRUPO FORMADO POR HIDROGENO, ALQUILO C SUB 1 QUILO C SUB 6 ALQUILO, CICLOALQUILO, CICLOALQUILALQUILO Y ARILO PUEDE ESTAR NO-SUSTITUIDO O SUSTITUIDO POR UN SUSTITUTO -OR SUB 4 DONDE R SUB 4 ES HIDROGENO O ALQUILO C SUB 1 ICLOALQUILALQUILO C SUB 6 OS ALQUILO, CICLOALQUILO Y CICLOALQUILALQUILO, PUEDE ESTAR SUSTITUIDO O NO POR UN SUSTITUTO ELEGIDO ENTRE: A) -OR SUB 4 DONDE R SUB 4 ES COMO SE HA DEFINIDO ANTERIORMENTE, Y B) (3) DONDE BIEN R SUB 5 Y R SUB 6 SE ELIGEN INDEPENDIENTEMENTE ENTRE EL GRUPO FORMADO POR HIDROGENO, ALQUILO C SUB 1 QUILO C SUB 1 LO HETEROMONOCICLICO SATURADO PENTALOMICO O HEXATOMICO, CONTENIENDO OPCIONALMENTE AL MENOS UN HETEROATOMO ADICIONAL ELEGIDO ENTRE OXIGENO Y NITROGENO; Y EL SIMBOLO (----) REPRESENTA UN ENLACE SENCILLO ODOBLE, Y SUS SALES FARMACEUTICAMENTE ACEPTABLES. EN VISTA DE SU ACTIVIDAD INHIBIDORA DE 5ALFA-REDUCTASA, LOS COMPUESTOS DE LA INVENCION PUEDEN SER UTILES PARA EL TRATAMIENTO DE CONDICIONES DEPENDIENTES DE ANDROGENOS.
ES91903236T 1990-02-09 1991-02-06 Derivados 17-g(b)-sustituido-4-aza-5g(a)-androstan-3-ona y procedimiento de preparacion de estos. Expired - Lifetime ES2080297T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909002922A GB9002922D0 (en) 1990-02-09 1990-02-09 17 beta-substituted-4-aza-5 alpha-androstan-3-one derivatives and process for their preparation

Publications (1)

Publication Number Publication Date
ES2080297T3 true ES2080297T3 (es) 1996-02-01

Family

ID=10670693

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91903236T Expired - Lifetime ES2080297T3 (es) 1990-02-09 1991-02-06 Derivados 17-g(b)-sustituido-4-aza-5g(a)-androstan-3-ona y procedimiento de preparacion de estos.

Country Status (26)

Country Link
US (1) US5155107A (es)
EP (1) EP0468012B1 (es)
JP (1) JPH04505462A (es)
KR (1) KR920701234A (es)
CN (1) CN1054771A (es)
AT (1) ATE128143T1 (es)
AU (1) AU642215B2 (es)
CA (1) CA2049318A1 (es)
CZ (1) CZ279484B6 (es)
DE (1) DE69113155T2 (es)
DK (1) DK0468012T3 (es)
ES (1) ES2080297T3 (es)
FI (1) FI914723A0 (es)
GB (1) GB9002922D0 (es)
GR (1) GR3017996T3 (es)
HR (1) HRP921221A2 (es)
HU (1) HUT59158A (es)
IE (1) IE910408A1 (es)
IL (1) IL97025A (es)
MY (1) MY105402A (es)
NO (1) NO913923L (es)
NZ (1) NZ237023A (es)
PT (1) PT96699A (es)
RU (1) RU2088589C1 (es)
WO (1) WO1991012261A1 (es)
ZA (1) ZA91918B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9115676D0 (en) * 1991-07-19 1991-09-04 Erba Carlo Spa Process for the preparation of 17 beta substituted-4-aza-5 alpha-androstan-3-one derivatives
CA2084799C (en) 1991-12-17 2003-01-28 Glenn J. Gormley Method of prevention of prostatic carcinoma with 17 beta-n-monosubstituted-carbamoyl-4-aza-5 alpha-androst-1 -en-3-ones
ES2118222T3 (es) * 1991-12-20 1998-09-16 Glaxo Wellcome Inc Inhibidores de 5-alfa-testosterona reductasa.
EP0641204B1 (en) * 1992-05-20 2000-08-16 Merck & Co. Inc. 17-ethers and thioethers of 4-aza-steroids
WO1993023419A1 (en) * 1992-05-20 1993-11-25 Merck & Co., Inc. NEW 7β-SUBSTITUTED-4-AZA-5α-CHOLESTAN-ONES AS 5α-REDUCTASE INHIBITORS
WO1993023048A1 (en) * 1992-05-20 1993-11-25 Merck & Co., Inc. 4-azasteroid 5-alpha-reductase inhibitors
WO1993023038A1 (en) * 1992-05-20 1993-11-25 Merck & Co., Inc. 17-AMINO SUBSTITUTED 4-AZASTEROID 5α-REDUCTASE INHIBITORS
EP0649306B1 (en) * 1992-05-20 2001-01-10 Merck & Co. Inc. Ester derivatives of 4-aza-steroids
US5237064A (en) * 1992-05-20 1993-08-17 Merck & Co., Inc. Process for producing 7β-substituted-aza-5αandrostan-3-ones
UA35589C2 (uk) * 1992-05-21 2001-04-16 Андорешерш Інк. ІНГІБІТОРИ ТЕСТОСТЕРОН 5-<font face="Symbol">a</font>-РЕДУКТАЗИ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ТА СПОСІБ ІНГІБУВАННЯ АКТИВНОСТІ ТЕСТОСТЕРОН 5-<font face="Symbol">a</font>-РЕДУКТАЗИ
GB9216284D0 (en) * 1992-07-31 1992-09-16 Erba Carlo Spa Fluorinated 17beta-substituted 4-aza-5alpha-androstane-3-one derivatives
GB9216329D0 (en) * 1992-07-31 1992-09-16 Erba Carlo Spa 17beta-substituted 4-aza-5alpha-androstan-3-one derivatives
GB9216280D0 (en) * 1992-07-31 1992-09-16 Erba Carlo Spa Steroids with a fluorinated acylureidic type side chain
US5302589A (en) * 1992-08-07 1994-04-12 Glaxo, Inc. Heterocyclic inhibitors of 5-α-testosterone reductase
HU212459B (en) * 1992-10-02 1996-06-28 Richter Gedeon Vegyeszet Process for producing new 17-beta-substituted 4-aza-androstane-derivatives and pharmaceutical compositions containing them
US5278159A (en) * 1992-10-06 1994-01-11 Merck & Co., Inc. Aryl ester derivatives of 3-oxo-4-aza-androstane 17-β-carboxylates as 5-α-reductase inhibitors
US5359071A (en) * 1993-03-12 1994-10-25 Merck & Co., Inc. 15-substituted 4-azasteroids
AU6413594A (en) * 1993-03-24 1994-10-11 Merck & Co., Inc. Substituted 3-phenanthridinone derivatives as 5alpha-reductase inhibitors
WO1995000147A1 (en) * 1993-06-28 1995-01-05 Merck & Co., Inc. 4-AZA-PREGNANE 5α-REDUCTASE ISOZYME 1 INHIBITORS
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
GB9415178D0 (en) * 1994-07-28 1994-09-21 Erba Carlo Spa 4-azasteroids with side-chain fluoroketones
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
CN1072679C (zh) * 1995-07-30 2001-10-10 重庆医科大学 一种氮杂甾体化合物、制备及其用途
GB9518858D0 (en) * 1995-09-14 1995-11-15 Pharmacia Spa Phenylsubstituted 4-azasteroid fluoroderivatives
CA2231434A1 (en) * 1995-09-27 1997-04-03 Glenn J. Gormley Method of preventing androgenetic alopecia with 5-.alpha. reductase inhibitors
GB9727522D0 (en) * 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Process for preparing carboxamido-4-azasteroids
US6645974B2 (en) * 2001-07-31 2003-11-11 Merck & Co., Inc. Androgen receptor modulators and methods for use thereof
CA2472475C (en) * 2002-01-15 2010-05-18 Merck & Co., Inc. 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators
KR100503193B1 (ko) * 2002-08-19 2005-07-25 한미약품 주식회사 3-옥소-4-아자-5α-안드로스탄 화합물의 선택적인 제조방법
EP1663199B1 (en) * 2003-09-25 2013-04-03 Tel Aviv University Future Technology Development L.P. Compositions and methods using same for treating amyloid-associated diseases
WO2005092341A1 (en) * 2004-03-22 2005-10-06 Ranbaxy Laboratories Limited Combination therapy for lower urinary tract symptoms
CN100355772C (zh) * 2005-12-28 2007-12-19 天津大学 具有5α-还原酶抑制活性的甾体化合物及其制备方法
WO2023070071A2 (en) * 2021-10-21 2023-04-27 The Board Of Trustees Of The University Of Illinois Small molecule activators of the immune system

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA970692A (en) * 1971-11-08 1975-07-08 Walter Voigt METHODS OF INHIBITING THE ACTIVITY OF TESTOSTERONE 5.alpha.-REDUCTASE
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
AU527030B2 (en) * 1978-04-13 1983-02-10 Merck & Co., Inc. 4-aza-17-substituted-5a-androstan-3-ones
US4220778A (en) * 1978-10-30 1980-09-02 G. D. Searle & Co. 8-Aryl-1,2,3,4-tetrahydroisoquinoline and derivatives thereof
US4220775A (en) * 1979-03-15 1980-09-02 Merck & Co., Inc. Preparation of 4-aza-17-substituted-5α-androstan-3-ones useful as 5α-reductase inhibitors
US4317817A (en) * 1979-08-27 1982-03-02 Richardson-Merrell Inc. Novel steroid 5α-reductase inhibitors
US4396615A (en) * 1981-06-24 1983-08-02 Duke University Method of treating androgen-related disorders
NZ211145A (en) * 1984-02-27 1988-10-28 Merck & Co Inc 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
GB8505862D0 (en) * 1985-03-07 1985-04-11 Erba Farmitalia Steroidic 5alpha-reductase inhibitors
US4845104A (en) * 1986-11-20 1989-07-04 Merck & Co., Inc. Oxidized analogs of 17β-N-monosubstituted-carbamoyl-4-aza-5-α-androstan-3-ones
NZ225100A (en) * 1987-06-29 1991-09-25 Merck & Co Inc Reaction of steroids (including 4-azasteroids) with a silylating agent in the presence of a quinone to introduce a delta' double bond and silylated intermediates

Also Published As

Publication number Publication date
CN1054771A (zh) 1991-09-25
KR920701234A (ko) 1992-08-11
EP0468012B1 (en) 1995-09-20
IE910408A1 (en) 1991-08-14
ZA91918B (en) 1991-11-27
AU642215B2 (en) 1993-10-14
RU2088589C1 (en) 1997-08-27
GR3017996T3 (en) 1996-02-29
NZ237023A (en) 1993-01-27
HRP921221A2 (en) 1995-12-31
DK0468012T3 (da) 1995-11-06
NO913923L (no) 1991-12-06
CS9100274A2 (en) 1991-12-17
NO913923D0 (no) 1991-10-07
CA2049318A1 (en) 1991-08-10
ATE128143T1 (de) 1995-10-15
PT96699A (pt) 1991-10-31
IL97025A (en) 1995-05-26
CZ279484B6 (cs) 1995-05-17
GB9002922D0 (en) 1990-04-04
JPH04505462A (ja) 1992-09-24
IL97025A0 (en) 1992-03-29
US5155107A (en) 1992-10-13
HU913193D0 (en) 1992-01-28
FI914723A0 (fi) 1991-10-07
DE69113155T2 (de) 1996-02-29
WO1991012261A1 (en) 1991-08-22
AU7230791A (en) 1991-09-03
DE69113155D1 (de) 1995-10-26
EP0468012A1 (en) 1992-01-29
MY105402A (en) 1994-09-30
HUT59158A (en) 1992-04-28

Similar Documents

Publication Publication Date Title
ES2080297T3 (es) Derivados 17-g(b)-sustituido-4-aza-5g(a)-androstan-3-ona y procedimiento de preparacion de estos.
FI913478A0 (fi) Diazinderivat.
ES2188584T3 (es) Derivados heterociclicos de amina.
MX9204661A (es) Compuestos intermedios derivados de eter y procedimiento para su preparacion.
NO921835L (no) Fremgangsmaate for fremstilling av amidinofenylalaninderivat samt anvendelse derav
ES8706654A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzotiazina
DE3667059D1 (en) Benzodipyrroles, processes for their preparation and pharmaceutical compositions containing these compounds
MX9702919A (es) Derivados azo del acido 5-aminosalicilico para el tratameitno de la enfermedad inflamatoria intestinal.
NO177713C (no) Analogifremgangsmåte ved fremstilling av hemoreguleringspeptider
IS4367A (is) CCK eða gastrín temprandi 5-heterósýklísk-1,5-bensódíazepín
NO891703L (no) Farmasoeytiske sammensetninger for behandling av psoriasis.
NZ217418A (en) Tricyclic heterocyclic compounds and pharmaceutical compositions
DE69330601D1 (de) Serotoninergische ergolin derivate
ES2104174T3 (es) Derivados de bencilamino, bencilamido y bencilimido ciclicos utilizados como agentes antipsicoticos.
ATE100439T1 (de) 2-(2-hydroxy-3-phenoxypropylamino)-ethoxybenzol derivate.
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
HUT70761A (en) Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof
FI834797A0 (fi) Foerfarande foer framstaellning av resorcinderivat
EP0194164A3 (en) N-carboxyalcoyl-2-oxo-3-diaryl-5,6-triazines useful as therapeutic agents
NO903585L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksaziner.
BG50776A1 (en) Derivatives of n- (2- phenylmorpholinomethyl)- succinamide and method for their preparation
MX9703610A (es) Nuevas (5,6)-heteroaril condensado-pirimidin-4-onas 2,3 disustituidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 468012

Country of ref document: ES